| Article | Added |
|---|
| FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer's Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) | 05-24-12 |
| Taro Provides Results for Three Months Ended March 2012 | 05-24-12 |
| BIO Lauds Senate Passage of User Fee Package | 05-24-12 |
| RetroSense Therapeutics Completes pre-IND Meeting for RST-001 | 05-24-12 |
| Teva Provides Updated 2012 Non-GAAP Financial Outlook; Updated 2012 Non-GAAP Diluted EPS of $5.30 to $5.40 | 05-24-12 |
| MDLinx Survey: Ninety Percent of US Oncologists Report Crucial Cancer Drug Shortage | 05-23-12 |
| BroadcastMed Changes Bariatric Business | 05-23-12 |
| Texas Workers Compensation Dept. Adopts Medical Treatment Guidelines Recommending STAR? Ankle Replacement System Exclusively | 05-23-12 |
| Furiex Confirms Takeda's Announcement on the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 Diabetes | 05-23-12 |
| Tonix Pharmaceuticals CEO Interviewed on CEOLive.TV | 05-23-12 |
| ETView Medical, Ltd. Announces US FDA Clearance of a 510(k) Pre-Marketing Notification Application for the VivaSight?-DL line of Innovative Airway Devices | 05-23-12 |
| PLx Pharma Files New Drug Application with FDA and Adds New Board Member | 05-22-12 |
| SYSPRO ERP Enables Compliance with Newly Added Food Safety Act Rules | 05-22-12 |
| Teleflex Receives FDA 510(k) Clearance for Antithrombogenic Claims on its ARROW® Peripherally Inserted Central Catheter (PICC) with Chlorag+ard® Technology | 05-21-12 |
| Viral Genetics? P-IND Clears FDA To Commence Clinical Trials in Humans | 05-21-12 |
| Medspira Receives FDA 510K Clearance for mcompass Anorectal Manometry Device | 05-21-12 |
| Transgenomic Announces CE IVD Mark for the WAVE MCE System and SURVEYOR® Scan KRAS Kit in Europe | 05-21-12 |
| FDA Approves New Labeling for ISENTRESS® (raltegravir) to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability with ISENTRESS in Combination Therapy in Previously Untreated Adult Patients Infected with HIV-1 | 05-21-12 |
| Health Outcomes Liaisons Improve Drug Reimbursement with Preemptive Payer Communication | 05-18-12 |
| ACRO Takes To Video To Advise FDA on Innovation | 05-18-12 |
| ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase 3 Clinical Trial of Tivantinib in Non-Small Cell Lung Cancer | 05-18-12 |
| Lantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time | 05-17-12 |
| Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses | 05-17-12 |
| Lantheus Appoints New Member to Its Board of Directors | 05-17-12 |
| Medgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis Patients | 05-17-12 |
| New Data from Bristol-Myers Squibb Oncology Portfolio to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting | 05-16-12 |
| Baron and Budd Warns Women About Side Effects of YAZ, Yasmin | 05-16-12 |
| ZOLL Honored for Excellence in Customer Satisfaction for 11th Consecutive Year | 05-16-12 |
| Clinical Data Published for a Phase I AADC-deficiency Trial Using a Gene Therapy Manufactured by Florida Biologix | 05-16-12 |
| Aggredyne Receives CE Mark for AggreGuideTM A-100 | 05-16-12 |
| Amneal Upgrades Generic Metformin Family by Listening to Customers | 05-16-12 |
| Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan | 05-16-12 |
| SORIN GROUP HA RICEVUTO L?APPROVAZIONE PER LA COMMERCIALIZZAZIONE DELL?ANELLO PER ANNULOPLASTICA MEMO 3D(TM) IN GIAPPONE | 05-16-12 |
| Avita Medical Initiates US FDA Study of Its ReCell® Spray-On-Skin? for Reconstructive and Aesthetic Indications | 05-15-12 |
| Minnetronix Enters Licensing Agreement with Penn State | 05-15-12 |
| U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept) | 05-15-12 |
| Beech Tree Labs Announces William J. Ryan's Appointment to Board of Directors | 05-15-12 |
| Furiex Pharmaceuticals Announces Agreement to Transfer Priligy® Product Rights | 05-14-12 |
| Furiex Pharmaceuticals and Menarini Announce License Agreement for Priligy® | 05-14-12 |
| SANUWAVE Reports First Quarter Financial Results | 05-14-12 |
| El Comité Asesor de la FDA respalda la aprobación del régimen Quad de única pastilla una vez al día para el VIH de Gilead | 05-14-12 |
| Bioness Announces FDA Clearance of Smaller Leg Cuff for Use with Its L300 Foot Drop System | 05-14-12 |
| Fibrocell Science Submits a Phase II Study Protocol to the FDA to Evaluate the Use of azficel-T in Treating Restrictive Burn Scars | 05-14-12 |
| Late-Stage Drugs Are Hotbed for Co-Development and Licensing Deals | 05-14-12 |
| Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-14-12 |
| New AVONEX® Dosing Innovations for People with Multiple Sclerosis Now Available in US | 05-14-12 |
| U-Systems Receives FDA PMA Approvable Letter for somo?v Automated Breast Ultrasound (ABUS) System | 05-14-12 |
| Biovest to Seek Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine | 05-14-12 |
| Biovest beantragt Marktzulassung für personalisierten Lymphom-Krebsimpfstoff BiovaxID® in der EU | 05-14-12 |
| Biovest va demander une autorisation de mise sur le marché dans l'UE pour le vaccin anticancéreux personnalisé contre le lymphome, BiovaxID® | 05-14-12 |
| Riassunto: Biovest presenterà una domanda di autorizzazione alla commercializzazione nell?Unione europea del vaccino personalizzato anticancro contro il linfoma BiovaxID® | 05-14-12 |
| FDA???????????????ICD?CRT-D??? | 05-14-12 |
| Le comité consultatif de la FDA en faveur de l?autorisation de mise sur le marché du Quad, le schéma posologique complet d?un comprimé unique quotidien anti-VIH de Gilead | 05-12-12 |
| FDA-Beratungsausschuss befürwortet Zulassung für Gileads einmal täglich einzunehmende Quad-Einzeltablette für HIV | 05-12-12 |
| FDA adviescommissie ondersteunt goedkeuring van het eenmaal daags Quad één tablet regime voor hiv | 05-12-12 |
| Il Comitato consultivo dell?FDA sostiene l?approvazione del regime monocompressa a somministrazione monogiornaliera Quad di Gilead per il trattamento dell?infezione da HIV | 05-12-12 |
| Le comité consultatif de la FDA soutient l'homologation du Truvada® de Gilead pour réduire le risque de contracter le VIH | 05-12-12 |
| Il Comitato consultivo dell'FDA sostiene l?approvazione del farmaco di Gilead Truvada® per la riduzione del rischio di contrazione dell?HIV | 05-12-12 |
| Vascular Expert Supports FDA Warning about Experimental Therapy for MS Patients | 05-11-12 |
| Adviescommissie van FDA steunt goedkeuring van Gilead's Truvada® voor verkleining van het risico op hiv-infectie | 05-11-12 |
| FDA Advisory Committee Supports Approval of Gilead's Once-Daily Quad Single Tablet Regimen for HIV | 05-11-12 |
| New Data from Landmark Study Shows Cost-Effectiveness of Medtronic Life-Saving CRT-D Therapy in Mildly Symptomatic Heart Failure Patients | 05-11-12 |
| FDA-Beratungsausschuss befürwortet Zulassung des Arzneimittels Truvada® von Gilead zur Senkung des HIV-Ansteckungsrisikos | 05-11-12 |
| El Comité Asesor de la FDA respalda la aprobación de Truvada® de Gilead para reducir el riesgo de adquirir VIH | 05-11-12 |
| Opexa Therapeutics Reports First Quarter 2012 Financial Results and Provides Corporate Update | 05-11-12 |
| FDA aprova a última geração de CDIs e CRT-DS da BIOTRONIK | 05-11-12 |
| FDA??BIOTRONIK??? ICD?CRT-D | 05-11-12 |
| La FDA approuve les DAI et les dispositifs CRT-D de nouvelle génération de BIOTRONIK | 05-11-12 |
| Riassunto: La FDA approva gli ICD e i CRT-D di BIOTRONIK di prossima generazione | 05-10-12 |
| FDA Advisory Committee Supports Approval of Gilead's Truvada® for Reducing the Risk of Acquiring HIV | 05-11-12 |
| La FDA aprueba la nueva generación de ICDs y CRT-Ds de BIOTRONIK | 05-10-12 |
| Regions hospital offers new alternative to open heart surgery | 05-10-12 |
| Samenvatting: FDA geeft goedkeuring aan volgende generatie BIOTRONIK ICD's en CRT-D's | 05-10-12 |
| FDA erteilt Zulassung für ICDs und CRT-Ds der nächsten Generation von BIOTRONIK | 05-10-12 |
| FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds | 05-10-12 |
| PharPoint Research is Recipient of CED's North Carolina Companies to Watch Award | 05-10-12 |
| SORIN GROUP ANNUNCIA L?APPROVAZIONE DELLA FDA ED IL LANCIO COMMERCIALE DELLA GAMMA COMPLETA DI ELETTROCATETERI PER DISPOSITIVI CARDIACI IMPIANTABILI | 05-10-12 |
| Interrad Medical Announces FDA Clearance for Additional Sizes of the SecurAcath Device | 05-10-12 |
| Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads | 05-10-12 |
| Las autoridades normativas de Estados Unidos y la Unión Europea aceptan para revisión las solicitudes para la comercialización de BG-12 oral | 05-10-12 |
| Eliminate Unwanted, Stubborn Belly Fat: Revolutionary CoolSculpting® Procedure Receives FDA Clearance to Treat Abdomen Area | 05-10-12 |
| Samenvatting: V.S. en E.U. autoriteiten accepteren marketingaanvraag voor oraal medicijn BG-12 | 05-10-12 |
| Synageva BioPharma to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-10-12 |
| Aufsichtsbehörden der USA und EU nehmen Marktzulassungsanträge für oral verabreichtes BG-12 zur Überprüfung an | 05-10-12 |
| Le autorità di regolamentazione di USA ed EU accettano di esaminare le richieste di commercializzazione di BG-12 in forma orale | 05-10-12 |
| Les autorités réglementaires américaines et de l'UE acceptent la demande de mise sur le marché du BG-12 par voie orale | 05-09-12 |
| Nitto Denko Obtains US Patent for Antifibrotic Therapies with Molecular Targeting DDS Technology | 05-09-12 |
| Kips Bay Medical Provides FDA Update and Reports First Quarter 2012 Results | 05-09-12 |
| Lantheus Medical Imaging Announces Manufacturing and Supply Agreements with Jubilant HollisterStier LLC for Cardiolite® and Neurolite® | 05-09-12 |
| US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review | 05-09-12 |
| BioRx Affirms Strong Supply of C1 Esterase Inhibitor Product | 05-09-12 |
| Press Teleconference TODAY: FDA Wants Magic HIV Prevention Pill Without Testing Says AHF | 05-09-12 |
| FDA Arthritis Advisory Committee Recommends Approval of Tofacitinib for Adult Patients with Moderately to Severely Active Rheumatoid Arthritis | 05-09-12 |
| New Study Shows Patients Can Effectively be Switched to Latuda® (lurasidone HCl) from Other Antipsychotic Agents | 05-09-12 |
| 2012 BIO International Convention to Highlight the FDA and Regulatory Environment | 05-09-12 |
| SORIN GROUP ANNOUNCES PUBLICATION OF FULL CLEAR STUDY RESULTS IN PEER REVIEWED CARDIOLOGY JOURNAL | 05-09-12 |
| SORIN GROUP ANNUNCIA LA PUBBLICAZIONE DEI RISULTATI COMPLETI DELLO STUDIO CLEAR SU EUROPACE, RIVISTA SCIENTIFICA SPECIALIZZATA IN CARDIOLOGIA | 05-09-12 |
| Courtagen Submits Pre-IDE Information Package for the Avantra® Q400 Workstation and QPDx® BioChip | 05-09-12 |
| Fidelity® Estimates Couples Retiring in 2012 Will Need $240,000 to Pay Medical Expenses Throughout Retirement | 05-09-12 |
| Guided Therapeutics Submits Response to FDA for LuViva® Advanced Cervical Scan PMA | 05-09-12 |
| St. Jude Medical Announces FDA Approval of Smaller ICD with Physician Inspired Shape | 05-09-12 |
| Provectus Pharmaceuticals? PV-10 Phase 2 Final Data To Be Presented At 2nd European PostASCO Melanoma Meeting 2012 on June 22, 2012 | 05-09-12 |
| MD&M East: Nelson Labs to Present Recent FDA Trends in Biocompatibility | 05-09-12 |
| EpiCept Reports First Quarter 2012 Operating and Financial Results | 05-09-12 |
| Santarus Reports First Quarter 2012 Financial Results | 05-08-12 |
| SORIN GROUP RICEVE L'APPROVAZIONE FDA E LANCIA SUL MERCATO LA NUOVA FAMIGLIA DI DISPOSITIVI CARDIACI IMPIANTABILI PARADYM(TM) RF | 05-08-12 |
| Sorin Group Announces FDA Approval and Commercial Launch of PARADYM(TM) RF ICDs and CRT-D Implantable Heart Devices | 05-08-12 |
| Cutting Edge Information Finds Early Dialogue with Payers Critical for Pharma Market Access Groups? Success | 05-08-12 |
| SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE | 05-08-12 |
| Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA | 05-08-12 |
| GTx Announces Removal of Full Clinical Hold By FDA for Capesaris® In Advanced Prostate Cancer | 05-08-12 |
| Resumen: Clinigen obtiene la aprobación de la FDA de Estados Unidos para Foscavir, un tratamiento del herpes y de las infecciones por citomegalovirus relacionadas con el VIH/SIDA | 05-08-12 |
| Samenvatting: Clinigen krijgt goedkeuring van Amerikaanse FDA voor Foscavir voor HIV/AIDS-gerelateerde cytomegalovirus infecties en herpes | 05-08-12 |
| ???????HIV/???????????????????????????????????????FDA???? | 05-08-12 |
| Clinigen erhält FDA-Genehmigung für Foscavir bei Cytomegalovirus-Infektionen in Zusammenhang mit HIV/AIDS und bei Herpes | 05-08-12 |
| Clinigen gains US FDA approval for Foscavir in HIV/AIDS-related cytomegalovirus infections and herpes | 05-08-12 |
| Clinigen obtient l'approbation de la FDA américaine pour Foscavir, un traitement de l'herpès et des infections à cytomégalovirus associées au VIH/SIDA | 05-08-12 |
| Riassunto: Clinigen ottiene dall'FDA l'approvazione per Foscavir nelle infezioni da citomegalovirus correlate a HIV/AIDS e da herpes | 05-08-12 |
| Affymax Reports First Quarter 2012 Financial Results | 05-07-12 |
| Minnesota Connected to Abbott Labs? Payment of $1.5 Billion to the Government in Fraud Case | 05-07-12 |
| Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance Treatment of Schizophrenia Presented at APA Annual Meeting | 05-07-12 |
| ???????(??)??????FDA?????????F-627??2???????? | 05-07-12 |
| ActiveSite Pharmaceuticals? Announces the Award of a Competitively Renewed Phase II SBIR Grant From the National Institutes of Health | 05-07-12 |
| Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia | 05-05-12 |
| Radiofrequency Ablation Prevents Local Cancer Recurrence as Effectively as Radiation Therapy, According to Research Presented at the American Society of Breast Surgeons Annual Meeting | 05-04-12 |
| Breastlink Medical Group to Offer iCAD's Xoft Radiation Therapy System to Breast Cancer Patients | 05-04-12 |
| KAMRA??????KFDA?????? | 05-04-12 |
| Napo Comments on FDA Announcing Extension of Crofelemer NDA Priority Review | 05-03-12 |
| Lantheus Medical Imaging Announces Appointment of Alexander E. Kuta, Ph.D., as Vice President, Global Regulatory Affairs and Nigel Williams as Vice President, Quality | 05-03-12 |
| Topera Medical's FDA-Cleared RhythmViewTM System Featured in 16 Presentations at Heart Rhythm Society 2012 Scientific Sessions | 05-03-12 |
| SNBL USA Demonstrates GLP Compliant Capabilities | 05-03-12 |
| Resumen: Knopp Biosciences anuncia contratación de importantes directivos científicos y finalización de ampliación de laboratorio | 05-03-12 |
| KAMRA??????????????????? | 05-03-12 |
| Pink Lotus Breast Center to Launch IORT Program Featuring iCAD's Xoft Radiation Therapy System for Breast Cancer Patients | 05-03-12 |
| Samenvatting: Knopp Biosciences rekruteert wetenschappelijke bestuursleden | 05-03-12 |
| Genzyme Announces Regulatory Approvals of Expanded Waterford, Ireland Manufacturing Plant | 05-03-12 |
| Knopp Biosciences annonce le recrutement de dirigeants pour occuper des postes scientifiques clés et l'agrandissement d'un laboratoire | 05-02-12 |
| Navidea Biopharmaceuticals Announces First Quarter 2012 Results | 05-02-12 |
| Exelixis Announces May 8th Webcast of Presentation at the Deutsche Bank Securities 37th Annual Health Care Conference | 05-02-12 |
| New York Parent Charges SimplyThick Infant Food Thickener Caused Catastrophic Injuries To Her Baby | 05-02-12 |
| AHF: New GAO Report Criticizes FDA over Drug Review Process | 05-02-12 |
| Riassunto: Knopp Biosciences annuncia il reclutamento di dirigenti scientifici di alto livello e il completamento dell'ampliamento del laboratorio | 05-02-12 |
| Knopp Biosciences Announces Recruiting of Key Scientific Executives and Completion of Laboratory Expansion | 05-02-12 |
| Pharmaceutical Market Access Groups Are More Influential When Independent | 05-02-12 |
| Allergan Reports First Quarter 2012 Operating Results | 05-02-12 |
| MEDA: Dymista approved by the FDA | 05-02-12 |
| El implante KAMRA? recibe la aprobación de la KFDA | 05-01-12 |
| KAMRA? Inlay Recebe Aprovação da KFDA | 05-01-12 |
| Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO? (taliglucerase alfa) For The Treatment Of Gaucher Disease | 05-01-12 |
| Brachytherapy as Effective for Local Breast Cancer Control as Whole Breast Irradiation According to New Study | 05-01-12 |
| Samenvatting: KAMRA inlegsel krijgt goedkeuring van Koreaanse Voedsel- en Medicijnenautoriteit | 05-01-12 |
| L'implant KAMRA? approuvé par la KFDA | 05-01-12 |
| ClinStar to Present at Outsourcing in Clinical Trials Europe | 05-01-12 |
| KAMRA? Inlay Receives KFDA Approval | 05-01-12 |
| Great Basin Corporation Receives FDA 510(k) Approval for C. Difficile Molecular Diagnostic Test | 05-01-12 |
| Riassunto: Lente KAMRA? riceve approvazione KFDA | 05-01-12 |
| KFDA genehmigt KAMRA? Inlay | 05-01-12 |
| Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models | 05-01-12 |
| Celldex Announces Plans to Release Topline Results from the EMERGE Study in Advanced Breast Cancer | 05-01-12 |
| Teleflex Enters into Definitive Agreement to Acquire Laparoscopic Fascial Closure System | 05-01-12 |
| A New Drug Used by 71-Year-Old Marathoner Don Wright Could Soon Be Approved to Help More Patients with Multiple Myeloma Says Tackle Cancer Foundation | 04-30-12 |
| Toshiba's Aquilion PRIME 80 CT System Receives FDA Clearance | 04-30-12 |
| The International Myeloma Foundation Says Pomalidomide, an Important New Drug for Patients, Has Been Submitted for FDA Approval | 04-27-12 |
| Navidea Biopharmaceuticals First Quarter 2012 Earnings and Business Update Conference Call Invitation | 04-27-12 |
| PerkinElmer Announces Financial Results for the First Quarter of 2012 | 04-26-12 |
| Pharmaceutical Patient Adherence Teams Increase Spending on Digital and Mobile Channels, Finds Cutting Edge Information | 04-26-12 |
| Repligen Provides Regulatory Update for RG1068 New Drug Application; FDA Cancels Advisory Committee Meeting | 04-26-12 |
| Theragenics Receives FDA Clearance to Market Galt VTI? Valved Tearaway Introducer | 04-26-12 |
| Spectranetics Achieves First Quarter Revenue of $33.3 Million | 04-26-12 |
| Furiex Confirms Takeda's Receipt of Complete Response Letter from the FDA for Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone | 04-26-12 |
| Invacare Corporation Announces Financial Results for the First Quarter of 2012 | 04-26-12 |
| Spectranetics Receives FDA Approval for Advanced GlideLightTM Laser Sheath | 04-25-12 |
| GE Healthcare Enhances Workflow in Echo Lab, OR and Cath Lab with Vivid E9 Cardiovascular Ultrasound, Now Including 4D TEE Transducer | 04-25-12 |
| Navidea Biopharmaceuticals Announces Participation in Alzheimer's Disease Scientific Meetings | 04-25-12 |
| Salix and Progenics Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 | 04-25-12 |
| Acorda Therapeutics Presents AMPYRA® Long-Term Safety and Efficacy Data at 64th American Academy of Neurology Annual Meeting | 04-25-12 |
| BioCryst to Report First Quarter 2012 Financial Results on May 7, 2012 | 04-25-12 |
| Toshiba's AIDR 3D Receives FDA Clearance | 04-25-12 |
| ??????????????FDA?????????????2012?9?????????? | 04-25-12 |
| Samenvatting: Positieve resultaten fase 3 CONFIRM klinische studie tonen effectiviteit bij orale BG-12 bij multiple sclerosis | 04-24-12 |
| FDA Approves Use of Codexis Enzymes in Merck Manufacturing Process | 04-24-12 |
| Significant Improvement in Disability Scores Observed in Multiple Sclerosis Patients Who Received LemtradaTM* (Alemtuzumab) Compared With Rebif® in Phase III Trial | 04-24-12 |
| Los resultados positivos del ensayo clínico CONFIRM de Fase 3 demuestran la seguridad y eficacia de BG-12 oral para la esclerosis múltiple | 04-24-12 |
| Positive Ergebnisse aus der klinischen Phase-3-Studie CONFIRM zeigen Wirksamkeit und Sicherheit von oral verabreichtem BG-12 bei multipler Sklerose | 04-24-12 |
| Becker Consulting Welcomes Six Leading FDA Experts to its Team | 04-24-12 |
| Dr. Reddy's Announces the Launch of Olanzapine Tablets | 04-24-12 |
| Avvo Releases Avvo Health Advisory (AHA) Providing Insights into Online Consumer Reviews of Medical and Dental Professionals | 04-24-12 |
| I risultati positivi dello studio clinico CONFIRM di fase 3 dimostrano l'efficacia e la sicurezza del farmaco orale BG-12 per la sclerosi multipla | 04-24-12 |
| Positive Results from Phase 3 CONFIRM Clinical Trial Show Efficacy and Safety of Oral BG-12 in Multiple Sclerosis | 04-24-12 |
| LDR Announces FDA Clearance and Launch of the ROI-C® Lordotic Cervical Cage | 04-24-12 |
| Les résultats positifs de l'essai clinique de phase 3 CONFIRM démontrent l'efficacité et l?innocuité du BG-12 sous forme orale dans le traitement de la sclérose en plaques | 04-24-12 |
| Greenleaf Health Expands Team of Medical Product Experts | 04-24-12 |
| Ironwood?Forest??FDA??Linaclotide???????2012?9? | 04-24-12 |
| OMONTYS® (Peginesatide) Injection Now Available for Adult Chronic Kidney Disease (CKD) Patients on Dialysis in the United States | 04-24-12 |
| Provectus Updates Shareholders in Its Annual CEO Letter | 04-24-12 |
| R-Tech Ueno: Completion of a Phase I Clinical Study of RK-023 for the Treatment of Hypotrichosis of the Eyelashes | 04-24-12 |
| American Shrimp Processing Industry Critical of Deepwater Horizon Settlement | 04-23-12 |
| Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis D | 04-23-12 |
| Phase IV Clinical Trials Outsourcing Booming to Meet Larger Goals, Finds Cutting Edge Information | 04-23-12 |
| Nearly Half of U.S. Adults Are Unaware of Recommended Vaccinations, Walgreens Survey Suggests | 04-23-12 |
| ViaValve Safety I.V. Catheter Receives 510(k) Clearance from the U.S. Food and Drug Administration | 04-23-12 |
| Samenvatting: Biogen Idec presenteert nieuwe data op American Academy of Neurology vergadering over veelbelovend therapieën voor neurologische ziekten | 04-23-12 |
| ACRO Testifies Before FDA on Clinical Trial Modernization | 04-23-12 |
| Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States | 04-23-12 |
| Samenvatting: Ironwood en Forest melden dat FDA inspectieperiode voor linaclotide tot september 2012 heeft verlengd | 04-23-12 |
| DuoFertility Service to Help Two Million ?Financially Infertile? US Couples | 04-23-12 |
| Spectrum Pharmaceuticals Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV® | 04-23-12 |
| Nuevos datos presentados en el 64º Congreso Anual AAN destacan el compromiso de Biogen Idec para ofrecer terapias prometedoras para necesidades no cubiertas en enfermedades neurodegenerativas | 04-23-12 |
| Grace and Formac Pharmaceuticals Announce Successful Clinical Trial Demonstrating the Novel Use of Silica for Drug Delivery | 04-23-12 |
| Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012 | 04-23-12 |
| Les nouvelles informations présentées à l?occasion de la 64ème conférence annuelle de l?AAN soulignent l?engagement de Biogen Idec à offrir des thérapies prometteuses pour les besoins non satisfaits... | 04-23-12 |
| Nuovi dati presentati al 64o incontro annuale dell'American Academy of Neurology (AAN) evidenziano l'impegno di Biogen Idec nello sviluppo di terapie promettenti per fabbisogni ancora insoddisfatti nelle malattie neurodegenerative | 04-22-12 |
| Carl Zeiss Meditec Announces a US Clinical Trial of a New Minimally Invasive, All-Femto Laser Vision Correction Method | 04-22-12 |
| Auf der 64. AAN-Jahrestagung präsentierte Daten unterstreichen das Engagement von Biogen Idec in der Entwicklung vielversprechender Therapien für Versorgungslücken im Bereich neurodegenerativer Erkrankungen | 04-21-12 |
| New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec's Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases | 04-20-12 |
| TomTec Receives FDA 510(k) Clearance for 2D Cardiac Performance Analysis© MR. | 04-20-12 |
| Five Key Trends in MSL Program Management | 04-20-12 |
| Incyte Announces EU Regulatory Milestone for Ruxolitinib | 04-20-12 |
| Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll Trials | 04-20-12 |
| Orphan Drug Designation Granted to SK Biopharmaceuticals? Carisbamate for the Management of Infantile Spasms | 04-19-12 |
| European Managed Markets Provide Hints at Potential U.S. Drug Pricing Policies, Says Cutting Edge Information | 04-19-12 |
| Carestream Health Receives FDA Clearance for New DRX-Revolution Mobile X-Ray System | 04-19-12 |
| Genzyme's Biologics Support Center Achieves LEED Gold Rating for Environmentally Responsible Design | 04-19-12 |
| Vertex fait progresser INCIVEK? (télaprévir) ainsi qu?un large portefeuille de médicaments au stade du développement avec comme objectif d?étendre et d?améliorer plus encore le traitement pour les personnes atteintes d?hépatite C | 04-18-12 |
| Vertex Advances INCIVEK? (telaprevir) and Broad Portfolio of Medicines in Development With Goal of Further Expanding and Improving Treatment for People With Hepatitis C | 04-18-12 |
| RedHill Biopharma Announces a Successful Pivotal Bioequivalence Trial with RHB-102 for the Prevention of Nausea and Vomiting in Cancer Patients | 04-18-12 |
| Quintiles? Digital Media Innovation Receives Further Recognition | 04-18-12 |
| NeuroMetrix Files 510(k) for SENSUS? Pain Therapy Device | 04-18-12 |
| BIO Submits Comments on FDA Draft Guidances on Biosimilars | 04-17-12 |
| BioClinica to Release First Quarter 2012 Financial Results on May 9, 2012 | 04-17-12 |
| IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results | 04-16-12 |
| ArQule Announces Completion of Common Stock Offering with Full Exercise of Option to Purchase Additional Shares | 04-16-12 |
| Drug Product Lifecycle Management Requires Multi-Pronged Strategy, Finds Cutting Edge Information | 04-16-12 |
| Chipotle Mexican Grill Responds to FDA's Voluntary Plan to Reduce Antibiotic Use in Farm Animals | 04-16-12 |
| Baxter and Halozyme Provide Update on HyQ Biologics License Application | 04-16-12 |
| Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer | 04-13-12 |
| InVivo Therapeutics Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries | 04-13-12 |
| Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study | 04-13-12 |
| BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval | 04-13-12 |
| 22nd?????????????????????????????FDA???? | 04-13-12 |
| Strategy Analytics: Security and Control Will Drive 2012 US Smart Home Revenues to $7.6 Billion | 04-12-12 |
| 22nd Century Group??FDA????????? | 04-12-12 |
| FDA Panel Recommends Approval for U-Systems? Breast Cancer Screening Tool for Women with Dense Breasts | 04-11-12 |
| Patient Adherence Budgets Skyrocket This Year as Brands Focus on Patient-Centric Strategies | 04-11-12 |
| Nelson Labs? Ethylene Oxide Sterilization Expert to Present at BIOMEDevice Boston Expo | 04-11-12 |
| Seafood ID from ACGT, Inc. Discusses the Appropriate Use of DNA Databases | 04-10-12 |
| 22nd Century Group to File Modified Risk Cigarette Applications with the FDA | 04-10-12 |
| Medtronic Receives FDA Approval to Treat Mildly Symptomatic Heart Failure Patients Through Expanded Indication for CRT-D | 04-10-12 |
| Nelson Labs Advises Reusable Medical Device Manufacturers to Follow New FDA Guidance | 04-10-12 |
| Vilex Introduces FUZE?- TTC Arthrodesis Compression Nail | 04-10-12 |
| Fenwal??????????Aurora??? | 04-10-12 |
| Phase 2 Data on Provectus's PV-10 to Be Presented at the HemOnc Today - Melanoma and Cutaneous Malignancies Conference on April 13, 2012 | 04-10-12 |
| EpiCept's AmiKet? Receives Fast Track Designation from FDA | 04-10-12 |
| Affymax Receives a $50 Million Milestone Payment for U.S. Approval of OMONTYS® (peginesatide) Injection | 04-09-12 |
| Over the Next 12 Months, Surveyed U.S. Oncologists Expect Zelboraf to Become More Deeply Ingrained in Medical Practice for the Treatment of BRAF Mutation-Positive Malignant Melanoma | 04-09-12 |
| OSI Systems Introduces qube? Patient Monitor | 04-09-12 |
| FDA Panel to Review New Breast Ultrasound Cancer Screening Tool | 04-09-12 |
| Spacelabs Healthcare Introduces the qube? Monitor | 04-09-12 |
| Devon Medical Products Receives FDA 510(k) Clearance for extriCARE? 2400 Negative Pressure Wound Therapy (NPWT) System | 04-05-12 |
| Orphan Diseases and the Future of BioPharma, the Focus of the 2012 Orphan Disease Forum | 04-05-12 |
| FDA Decides Teva is Sole First-to-File on Provigil® | 04-05-12 |
| FDA???Fenwal???Amicus®??????????????? | 04-05-12 |
| Samenvatting: Dieter Bielang wordt International Sales Director Europe van Sapheon | 04-04-12 |
| Resumen: Dieter Bielang se incorpora a Sapheon como director internacional de ventas en Europa | 04-04-12 |
| Anulex Technologies, Inc. Announces FDA Clearance for Expanded Indications of fiXate? Tissue Band | 04-04-12 |
| GTx Submits Clinical Hold Complete Response Letter To FDA For Its Planned Phase II Clinical Study Of Capesaris® For Secondary Hormonal Therapy of Advanced Prostate Cancer | 04-04-12 |
| TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development | 04-04-12 |
| Dieter Bielang rejoint Sapheon en qualité de directeur des ventes internationales pour l'Europe | 04-04-12 |
| ?????????????????Aurora???????? | 04-04-12 |
| Dieter Bielang wird internationaler Vertriebsleiter von Sapheon in Europa | 04-04-12 |
| Riassunto: Dieter Bielang diventa direttore commerciale internazionale di Sapheon per l'Europa | 04-04-12 |
| The Multiple Myeloma Research Foundation (MMRF) Presents Study Design for Landmark Trial Focused on Genomic Analysis at the AACR Annual Meeting | 04-03-12 |
| Dieter Bielang Joins Sapheon As International Sales Director, Europe | 04-03-12 |
| Companion Diagnostics Budgets Topping $1 Million as Companies Build Personalized Medicine into Drug Development Strategy, Finds Cutting Edge Information | 04-03-12 |
| Samenvatting: Fenwal introduceert nieuw Aurora-systeem voor plasmacollectie | 04-03-12 |
| REPEAT/ Neupro® Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome | 04-03-12 |
| JAVA Article: Clinician Surveys Help in Fight Against Bloodstream Infections | 04-03-12 |
| FDA Extends PDUFA Date for Lymphoseek® by Three Months | 04-03-12 |
| Fenwal Introduces New Aurora? System for Plasma Collection | 04-03-12 |
| Fenwal introduit le nouveau système Aurora? pour le prélèvement de plasma | 04-03-12 |
| Fenwal stellt das System New Aurora? für Plasmaentnahme vor | 04-03-12 |
| Fenwal Presenta el Nuevo Sistema Aurora? para Recolección de Plasma | 04-03-12 |
| Fenwal apresenta novo sistema Aurora? para coleta de plasma | 04-03-12 |
| Riassunto: Fenwal lancia il nuovo sistema Aurora? per la raccolta del plasma | 04-03-12 |
| Estech Announces FDA Approval to Begin Enrollment in ATTAC-AF IDE Trial for the Treatment of Atrial Fibrillation During Cardiac Surgery | 04-03-12 |
| ?????????????Amicus®????????????FDA?????? | 04-03-12 |
| Neupro® Approved by U.S. FDA for Parkinson's Disease and Restless Legs Syndrome | 04-03-12 |
| Fenwal erhält FDA-Zulassung für den therapeutischen Plasmaaustausch mit seinem Amicus®-Separator | 04-02-12 |
| Fenwal reçoit l'autorisation de la FDA pour l'échange de plasma thérapeutique sur son système Amicus® Separator | 04-02-12 |
| Samenvatting: Fenwal ontvangt FDA goedkeuring voor therapeutische plasma-uitwisseling met zijn Amicus Separator | 04-02-12 |
| GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer | 04-02-12 |
| Fenwal recebe aprovação da FDA para troca terapêutica de plasma no seu separador Amicus® | 04-02-12 |
| Cannabis Science Continues Forward with FDA IND Process as Patients Report Successful Cancer Treatments | 04-02-12 |
| Riassunto: Fenwal ottiene l'autorizzazione dell'FDA per la plasmaferesi terapeutica per il suo separatore Amicus® | 04-02-12 |
| The Multiple Myeloma Research Foundation (MMRF) and Translational Genomics Research Institute Announce Innovative Molecular Profiling and Biobanking Collaboration for Landmark Multiple Myeloma Study | 04-02-12 |
| Fenwal Receives FDA Clearance for Therapeutic Plasma Exchange on Its Amicus® Separator | 04-02-12 |
| AlloCure Raises $25 Million Series B Venture Financing | 04-02-12 |
| Spacelabs Healthcare Launches ArkonTM High-Performance Anesthesia Delivery System | 04-02-12 |
| NanoKnife® System Clinical Experience Featured at Society of Surgical Oncology Conference | 04-02-12 |
| NanoViricides Announces Successful Pre-IND Meeting with the US FDA | 04-02-12 |
| Osteoarthritis Treatment Guidelines Issued by American College of Rheumatology Discussed Use of Topical NSAIDS for Patients 75 and Older | 03-30-12 |
| Teva Announces Launch of Authorized Generic of Provigil® | 03-30-12 |
| US District Court Finds SEROQUEL XR Formulation Patent Valid and Infringed | 03-29-12 |
| Genzyme and Isis Announce Submission of U.S. NDA for KYNAMRO? (mipomersen sodium) in Homozygous Familial Hypercholesterolemia | 03-29-12 |
| Tau Therapeutics LLC to Present Posters at AACR on T-Type Calcium Channel Inhibitors and Interlaced Therapy | 03-29-12 |
| Forest Laboratories and Almirall Announce FDA has Extended the Review Period for Aclidinium Bromide | 03-29-12 |
| EpiCept to Raise $1.1 Million in Registered Direct Offering | 03-29-12 |
| Smiths Medical Issues a Market Withdrawal for CoZmonitor Blood Glucose Monitoring Systems | 03-28-12 |
| ClinStar to Present at 4th Oncology Clinical Trials in Emerging Regions Conference | 03-28-12 |
| FDA aprueba el sistema LINX® para el tratamiento de la enfermedad por reflujo | 03-28-12 |
| Teva Announces Launch of Generic Seroquel® in the United States | 03-28-12 |
| Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Phase 3 Data at Society of Surgical Oncology Meeting | 03-28-12 |
| FDA Commissioner Hamburg ?Must Go? Says AHF | 03-28-12 |
| US-Arzneimittelzulassungsbehörde FDA erteilt Zulassung für LINX® System zur Behandlung von Refluxkrankheit | 03-27-12 |
| La FDA agrée le système LINX® pour le traitement du reflux gastro-'sophagien | 03-27-12 |
| FDA keurt LINX®-systeem goed voor de behandeling van reflux | 03-27-12 |
| Cannabis Science Reports Its First Documentary Release Date of April 5, 2012 ?CHRONIC FUTURE - KILLING CANCER? A DOCUMENTARY ABOUT THE TRUTH AND BENEFITS OF MEDICAL MARIJUANA | 03-27-12 |
| Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis | 03-27-12 |
| La FDA approva il sistema LINX® per il trattamento della malattia da reflusso | 03-27-12 |
| FDA Approves LINX® System for the Treatment of Reflux Disease | 03-27-12 |
| Teva Announces FDA Approval of QNASLTM (beclomethasone dipropionate), a New Nonaqueous Nasal Aerosol, for the Treatment of Allergic Rhinitis | 03-26-12 |
| US Court Denies Preliminary Injunction Application against the FDA and Dismisses AstraZeneca's Lawsuit without Prejudice | 03-26-12 |
| Medtronic Resolute® Drug-Eluting Stent Delivers Durable Clinical Outcomes Through Two Years in Major Studies | 03-24-12 |
| St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement | 03-23-12 |
| Hyperion Therapeutics Acquires Ravicti? (Glycerol Phenylbutyrate) From Ucyclyd Pharma, Inc. | 03-23-12 |
| BIO Praises Senate Passage of the Jumpstart Our Business Startups (JOBS) Act | 03-22-12 |
| Covidien's Mallinckrodt Business Launches Morphine Sulfate Oral Solution in U.S. | 03-22-12 |
| Mazor Robotics to Announce Fourth Quarter and Full Year 2011 Financial Results and Conduct Conference Call on Wednesday, March 28, 2012 | 03-22-12 |
| Additional Scientific Perspective Offered on Pending FDA Decision on BPA | 03-21-12 |
| Anulex Technologies, Inc. Resolves FDA Warning Letter | 03-21-12 |
| Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas | 03-20-12 |
| First Australian Patients Enrolled in Gore Global Registry for Endovascular Aortic Treatment | 03-20-12 |
| Samenvatting: Covidien meldt FDA 510(k) toestemming voor Nellcor Respiration Rate Software | 03-20-12 |
| Resumen: Covidien anuncia la aprobación 510(k) de la FDA relativa al software de supervisión de la frecuencia respiratoria NellcorTM | 03-20-12 |
| Terason and Soma Receive FDA Clearance for New Needle Visualization Technology | 03-20-12 |
| Covidien Announces FDA 510(k) Clearance of Nellcor? Respiration Rate Software | 03-20-12 |
| Covidien gibt FDA-510(k)-Zulassung der Nellcor? Respiration Rate Software bekannt | 03-20-12 |
| Riassunto: Covidien annuncia approvazione FDA 510(k) del software Nellcor? Respiration Rate | 03-20-12 |
| Covidien annonce l'approbation 510(k) de la FDA relative au logiciel de surveillance de la fréquence respiratoire Nellcor? | 03-20-12 |
| Advanced Bionics Launches ClearVoice in the United States | 03-19-12 |
| TRADE NEWS: Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella | 03-19-12 |
| FDA Accepts PaxVax's IND for Single-Dose Oral Cholera Vaccine | 03-19-12 |
| Cameron Health's S-ICD® System Scheduled for FDA Panel Review on April 26, 2012 | 03-19-12 |
| EffRx???FDA???BINOSTO®??????????????????????????????? | 03-19-12 |
| EffRx??????????????????????????BINOSTO®?FDA?????? | 03-16-12 |
| Samenvatting: EffRx meldt: FDA keurt BINOSTO goed, eerste en enige behandeling van botontkalking | 03-15-12 |
| Simpirica Spine Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex? Spinal Stabilization System | 03-15-12 |
| BioCardia and Juventas Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure | 03-14-12 |
| A EffRx Anuncia: A FDA aprova BINOSTO®, Primeiro e Único Tratamento de Osteoporose Efervescente em uma Solução Tamponada | 03-14-12 |
| EffRx annonce : La FDA approuve BINOSTO®, le premier et le seul traitement effervescent contre l'ostéoporose sous forme de solution tamponnée | 03-14-12 |
| SANUWAVE Reports 2011 Financial Results and Provides Update on dermaPACE FDA Status | 03-14-12 |
| Riassunto: EffRx annuncia che BINOSTO®, l'innovativo ed esclusivo trattamento effervescente contro l'osteoporosi in soluzione tampone, ha ricevuto l'approvazione da parte della FDA | 03-14-12 |
| Anuncio de EffRx: La FDA aprueba BINOSTO®, el primer y único tratamiento efervescente para la osteoporosis en una solución tamponada | 03-14-12 |
| EffRx meldet FDA-Zulassung für BINOSTO®, das erste und einzige Osteoporosemittel in Form einer gepufferten Brausetablette | 03-14-12 |
| Effrx Announces: FDA approves BINOSTO®, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution | 03-14-12 |
| Cell>Point Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Trial of Technetium-99m-EC-G for Imaging Lung Cancer | 03-13-12 |
| AHF Asks ?What's Rotten at FDA?? in New Politico Playbook Ads | 03-13-12 |
| AstraZeneca Files Lawsuit against the FDA for Decision Regarding Quetiapine Product Labeling and Exclusivity | 03-13-12 |
| LifeGas President Mike Walsh Testifies Before Congress in Support of Medical Gas Safety Act; Says Legislation Necessary to Reduce Uncertainty and Ensure Reliable Supply | 03-12-12 |
| Cannabis Science Confirms Target Indication for FDA and Prepares for Pre-IND Meeting with the FDA with Its Team of FDA Specialists | 03-12-12 |
| Aradigm Receives U.S. FDA Clearance for Phase 3 Clinical Trial of Pulmaquin? in Patients with Non-Cystic Fibrosis Bronchiectasis | 03-12-12 |
| Des données montrent que le régime Quad de Gilead contre le VIH n'est pas inférieur au régime à base de protéase à 48 semaines de la seconde étude pivot de Phase 3 | 03-09-12 |
| Gegevens tonen aan dat Gilead's Quad-regime voor hiv niet-inferieur is aan op protease gebaseerd regime na 48 weken, in tweede cruciale Fase 3-studie | 03-09-12 |
| Sientra® Receives FDA Approval of Its Silimed®-Brand Portfolio of Round and Shaped Silicone Breast Implants | 03-09-12 |
| I dati di un secondo importante studio di Fase III dimostrano la non inferiorità del regime Quad di Gilead per il trattamento dell?infezione da HIV rispetto a un regime basato su inibitori della proteasi dopo 48 settimane di trattamento | 03-09-12 |
| Los datos muestran que el régimen Quad de Gilead para el VIH no es inferior al régimen basado en proteasa a las 48 semanas en un segundo estudio fundamental de Fase 3 | 03-09-12 |
| Quad-HIV-Präparat von Gilead nach 48 Wochen nicht unterlegen gegenüber Behandlung auf Protease-Basis: Beleg durch Daten einer zweiten Pivotstudie der Phase 3 | 03-09-12 |
| Resumen: Avedro anuncia presentación de autorización ante la FDA de cross-linking para córnea | 03-09-12 |
| Samenvatting: Avedro meldt zijn FDA aanvraag voor corneale cross-linking | 03-09-12 |
| FDA Responds to AstraZeneca Citizen Petitions on Quetiapine Product Labeling | 03-09-12 |
| Avedro annonce avoir soumis auprès de la FDA une demande d'autorisation portant sur la réticulation cornéenne | 03-09-12 |
| Data Show Gilead's Quad Regimen for HIV Non-Inferior to Protease-Based Regimen at 48 Weeks in Second Pivotal Phase 3 Study | 03-09-12 |
| New Treatment Presented for Chronic Diarrhea in HIV/AIDS Patients | 03-08-12 |
| BIO Hails Senate Passage of PAHPA Reauthorization | 03-08-12 |
| Non infériorité comparé à l?Atripla® du schéma posologique anti-VIH « Quad » sous forme d?un comprimé unique de Gilead démontrée dans une étude pivot de Phase 3 | 03-08-12 |
| Riassunto: Avedro annuncia la presentazione della richiesta alla FDA per il cross-linking corneale | 03-08-12 |
| Avedro reicht Antrag auf FDA-Zulassung für Hornhautquervernetzung ein | 03-08-12 |
| De ?Quad?-kuur van Gilead, bestaande uit één tablet tegen HIV doet niet onder voor Atripla® in fase 3 hoofdstudie | 03-08-12 |
| Cannabis Science Reports Cancer Tumors Continues to Shrink and Die as Apparent Pieces of the Dying Cancer Tumors Begin to Fall off as Evidenced in Newest Photos of the 3rd Squamous Cell Carcinoma Patient | 03-08-12 |
| Avedro Announces FDA Submission for Corneal Cross-linking | 03-08-12 |
| El régimen Quad de única pastilla de Gilead para el VIH no es inferior a Atripla® en el estudio fundamental de fase 3 | 03-08-12 |
| Quad-Einzeltablette von Gilead gegen HIV in Pivotstudie der Phase 3 gegenüber Atripla® nicht unterlegen | 03-08-12 |
| Dimostrata la non inferiorità del regime monocompressa Quad di Gilead per il trattamento dell?HIV rispetto ad Atripla® in uno studio pivotale di Fase III | 03-08-12 |
| Teva Receives FDA Approval for ProAir® HFA (albuterol sulfate) with Dose Counter | 03-08-12 |
| Hi-Tech Pharmacal Reports Sales of $55.6 Million and EPS of $0.79 for the Third Quarter Ended January 31, 2012 | 03-08-12 |
| Osprey Medical Launches Underwritten IPO to Raise A$20 Million and Has Applied to List on the Australian Securities Exchange | 03-08-12 |
| AHF Files ?Citizen's Petition? with FDA to ?Delay or Deny? Approval of Gilead's HIV ?Prevention? Pill | 03-08-12 |
| Gilead's Quad Single Tablet Regimen for HIV Non-Inferior to Atripla® in Pivotal Phase 3 Study | 03-07-12 |
| Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) | 03-07-12 |
| AMAG Pharmaceuticals Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency Anemia | 03-07-12 |
| 2012 BIO International Convention Super Sessions Focus on Industry Outlook | 03-07-12 |
| Covidien Peripheral Vascular Stent System Receives FDA Approval | 03-07-12 |
| Viral Genetics Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA | 03-07-12 |
| Eisai Inc. Receives Complete Response Letter from the U.S. Food and Drug Administration for Dacogen® (decitabine) for Injection sNDA in Acute Myeloid Leukemia | 03-07-12 |
| Eisai Inc. Receives Complete Response Letter from U.S. Food and Drug Administration for DACOGEN® (decitabine) for injection sNDA in Acute Myeloid Leukemia | 03-07-12 |
| Columbia Laboratories Receives Nasdaq Minimum Bid Price Non-compliance Letter | 03-06-12 |
| Crosstrees Medical, Inc. Completes Enrollment of USA IDE Study for Percutaneous Vertebral Augmentation (PVA) | 03-06-12 |
| FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies | 03-06-12 |
| Allos Therapeutics Reports Fourth Quarter and Full Year 2011 Financial Results | 03-06-12 |
| Avinger Enrolls First U.S. PAD Patient in CONNECT II Global Clinical Trial | 03-06-12 |
| Baxano Receives CE Mark for iO-Flex® System | 03-06-12 |
| Derma Sciences Meeting with FDA Supports Initiation of Phase 3 Studies with DSC127 in Diabetic Foot Ulcers | 03-06-12 |
| FDA Accepts Resubmission of Perampanel New Drug Application | 03-05-12 |
| Cannabis Science Targets Opportune Immediate European Expansion With Acquisitions & Licensing Deals; Negotiations For First European Deal Is In Final Stages For New Products, Revenues, and Management | 03-05-12 |
| CORRECTING and REPLACING Repligen Announces Submission of Marketing Authorization Application in EU for SecreFlo? to Improve Pancreatic Imaging in Patients with Pancreatitis | 03-05-12 |
| UE LifeSciences Inc. Announces FDA Clearance for Complementary Breast Cancer Screening Device | 03-05-12 |
| NanoViricides Announces US FDA Has Confirmed Pre-IND Meeting Date | 03-05-12 |
| Repligen Announces Submission of Marketing Authorization Application in EU for SecreFlo? to Improve Pancreatic Imaging in Patients with Pancreatitis | 03-05-12 |
| Covidien Revascularization Device Receives FDA Clearance | 03-05-12 |
| APP Pharmaceuticals Announces Expanded Supply of Methotrexate Injection, USP | 03-03-12 |
| Dateline NBC Report on Overseas Medical Research Strengthens ACRO Argument for Increased FDA Funding | 03-02-12 |
| Cannabis Science Issues Potential Revenues And Market Data for the New Cannabis Science Brand OTC Products | 03-02-12 |
| Thermo Fisher Scientific Announces 510(k) Clearance of ImmunoCAP Tryptase Assay | 03-02-12 |
| K2M Expands Complex Spine Product Offering with 510(k) Clearance for SANTORINI? Corpectomy Cage Systems | 03-01-12 |
| Genzyme Begins Shipping Fabrazyme from Newly Approved Framingham Manufacturing Plant | 03-01-12 |
| Cook Medical Receives Japanese Approval to Market Its Zilver® PTX® Drug-Eluting Stent | 03-01-12 |
| APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") Announce the European Approval of Zolmitriptan Oral Dispersible Film (ODF) | 03-01-12 |
| U.S. Food and Drug Administration Extends Action Date for ELIQUIS® (apixaban) by Three Months | 03-01-12 |
| Globus Medical and David C. Paul, Agree to Settle FDA Administrative Complaint | 02-29-12 |
| Phase III studies of Jakafi? (ruxolitinib) published in The New England Journal of Medicine Demonstrate Significant Clinical Benefit for Patients with Myelofibrosis | 02-29-12 |
| Genzyme Recognizes International Rare Disease Day with Second Annual Patient Advocacy Grant Program | 02-29-12 |
| Samenvatting: Biogen Idec levert aanvraag in bij FDA voor goedkeuring van orale BG-12 voor behandeling van Multiple Sclerosis | 02-29-12 |
| Tau Therapeutics IND Accepted by FDA for Novel Cancer Drug | 02-28-12 |
| Biogen Idec presenta solicitud a la FDA para aprobación del BG-12 oral para el tratamiento de la esclerosis múltiple | 02-28-12 |
| Samsung Biologics y Biogen Idec anuncian formación de la joint-venture de biosimilares, Samsung Bioepis | 02-28-12 |
| Bayer Maintains Sales Growth in North America | 02-28-12 |
| Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis | 02-28-12 |
| FDA Approves AVONEX® PEN? and Dose Titration Regimen | 02-28-12 |
| Biogen reicht Zulassungsantrag für oral verabreichtes BG-12 zur Behandlung von multipler Sklerose bei der FDA ein | 02-28-12 |
| Biogen Idec deposita una domanda di approvazione di un nuovo farmaco presso l'Agenzia per gli Alimenti e i Medicinali statunitense (Food and Drug Administration, FDA) per l'approvazione di Oral BG-12 per il trattamento della sclerosi multipla | 02-28-12 |
| Biogen Idec soumet à la FDA une demande d'homologation du BG-12 sous forme orale pour le traitement de la sclérose en plaques | 02-28-12 |
| Samenvatting: Samsung Biologics en Biogen Idec richten biosimilars joint venture op: Samsung Bioepis | 02-28-12 |
| Samsung Biologics und Biogen Idec gründen Biosimilars-Jointventure Samsung Bioepis | 02-28-12 |
| Samsung se asocia con Qualcomm y ARM Technologies para llevar contenido de video HD premium a los usuarios móviles | 02-28-12 |
| Le programme de développement clinique du patch de désensibilisation à l?arachide Viaskin Peanut reçoit la désignation « Fast Track » de la FDA | 02-28-12 |
| Samsung Biologics e Biogen Idec annunciano la formazione della joint venture di biosimilari, Samsung Bioepis | 02-28-12 |
| Samsung Biologics et Biogen Idec annoncent la formation de la coentreprise Samsung Bioepis dans le domaine des médicaments bio-similaires | 02-28-12 |
| Samsung Biologics and Biogen Idec Announce Formation of Biosimilars Joint Venture Samsung Bioepis | 02-28-12 |
| Meridian Bioscience Receives FDA Clearance for New Legionella Test | 02-27-12 |
| Pfizer Acquires Alacer Corp., a Leading Vitamin Supplements Company | 02-27-12 |
| Opexa Therapeutics Reports Year End 2011 Financial Results and Provides Corporate Update | 02-27-12 |
| FDA Panel Meeting Scheduled for U-Systems? Automated Breast Ultrasound (ABUS) System | 02-27-12 |
| ?????????????????ELISA?????? DS2?????????'sFDA??????? | 02-27-12 |
| Forest and Almirall Announce Positive FDA Advisory Committee's Recommendation for Approval of Aclidinium Bromide for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) | 02-24-12 |
| Ascendx Spine? receives FDA clearance to market its Acu-Cut Vertebral Augmentation System | 02-23-12 |
| Cannabis Science Presents Newest Case Photos of the 3rd Critical Squamous Cell Carcinoma Self-Medicated Cannabis Patient with Clear Continued Improvement | 02-23-12 |
| Resumen: La instalación biofarmacéutica de Eurogentec supera con éxito la inspección de la FDA de EE.UU | 02-23-12 |
| FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma | 02-23-12 |
| SFDA??Dynex Technologies?????DS2??ELISA???? | 02-23-12 |
| L'unité « Biologique » d'Eurogentec satisfait aux critères de la procédure d'inspection de la FDA américaine | 02-23-12 |
| ?????????????????????FDA?????????? | 02-23-12 |
| FDA Accepts Impax Pharmaceuticals NDA Filing for IPX066 for the Treatment of Idiopathic Parkinson's Disease | 02-23-12 |
| Samenvatting: Eurogentecs biotechnische fabriek doorstaat met succes US FDA inspectie | 02-23-12 |
| The Pacific Northwest's Leading Life Sciences Association Represented at White House Business Council Conference | 02-23-12 |
| Erfolgreicher Abschluss der FDA-Prüfung des Biopharmazeutikawerks von Eurogentec | 02-23-12 |
| Riassunto: Lo stabilimento per la produzione di biofarmaci di Eurogentec ha passato con successo l'ispezione statunitense della FDA | 02-22-12 |
| Dynex Technologies Receives SFDA Approval to Supply DS2 Automated ELISA Processing System to China | 02-22-12 |
| Eurogentec's Biologics Facility Successfully Completes US FDA Inspection | 02-22-12 |
| Mascoma Announces FDA Favorable Review of Drop-In MGT? Yeast Product | 02-22-12 |
| APP Pharmaceuticals Announces Approval of Preservative-Free Methotrexate Injection, USP | 02-22-12 |
| Applications Requested for First-Ever Medical Device Accelerator | 02-21-12 |
| BRILINTA® (ticagrelor) Added to American College of Chest Physicians Recommendations on Antithrombotic Therapy and Prevention of Thrombosis | 02-21-12 |
| IntelliCell BioScience Inc. Procedure Enables Norwegian Star Basketball Player to Fully Recover from Patella Tendinitis to Play for Manhattan College | 02-21-12 |
| Enzo Biochem Receives Approval for Novel Blood Based Test for Colorectal Cancer Risk | 02-21-12 |
| Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors | 02-21-12 |
| Repligen Announces FDA Grant of Priority Review for SecreFlo? NDA | 02-21-12 |
| Academic Detailing Impact on Pharma Industry Discussed in New Study Published at MarketPublishers.com | 02-20-12 |
| Medtronic Resolute Integrity Drug-Eluting Stent Obtains FDA Approval for Treating Coronary Artery Disease | 02-17-12 |
| ACRO Implores CMS To Limit Research Definition For Sunshine Reporting | 02-17-12 |
| InVivo Therapeutics? CEO Frank Reynolds Scheduled to Appear on Fox News First and San Antonio Living | 02-17-12 |
| AHF Asks ?What's rotten at FDA?? in New Politico Ad | 02-16-12 |
| AstraZeneca Announces First Direct-to-Patient Program Offering the Brand ARIMIDEX® (anastrozole) Tablets to Patients for Only $40 Per Month | 02-16-12 |
| AHF Challenges FDA Move to Fast Track Gilead's ?HIV Prevention? Drug Linked to Kidney Disease | 02-16-12 |
| BIO Industry Analysis Investor Survey: FDA Approvals Expected to Increase and Majority of Investors Believe Now Is a Good Time to Invest in Biotech | 02-15-12 |
| TREAT Act Offers Renewed Hope for Patients | 02-15-12 |
| RedHill Biopharma Commences Advanced Clinical Trial with RHB-102 (Prevention of Nausea and Vomiting in Cancer Patients); Subjects Recruitment Completed; First Dosing Took Place; Results Expected Within Months | 02-15-12 |
| BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel? | 02-15-12 |
| New Study Shows a Free Plant Based Sterol/Stanol Dietary Supplement, CholestOff, Significantly Lowers ?Bad? Cholesterol Levels by Almost 5 Percent | 02-15-12 |
| FDA Accepts Pfizer's New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) | 02-15-12 |
| Biogen Idec adquiere Stromedix | 02-15-12 |
| Santarus Announces FDA Acceptance of UCERIS New Drug Application for Induction of Remission of Active Ulcerative Colitis | 02-15-12 |
| Cannabis Science Signs Multi-Company Acquisition & Licensing Deals that will Boost Revenues, Its Pharmaceutical Operations and Management Team While Bringing Cannabis Science Brand Products For National Distribution | 02-14-12 |
| Key Clinical Trial of Alzheimer's Disease Drug Begins in Europe | 02-14-12 |
| Samenvatting: Biogen Idec neemt Stromedix over | 02-14-12 |
| Diffusion Pharmaceuticals????????????????? TSC?????? | 02-14-12 |
| Biogen Idec to Acquire Stromedix | 02-14-12 |
| Biogen Idec rachète Stromedix | 02-14-12 |
| Biogen Idec übernimmt Stromedix | 02-14-12 |
| Biogen Idec acquisirà Stromedix | 02-14-12 |
| Velomedix Receives IDE Approval to Evaluate the Use of Rapid Therapeutic Hypothermia in the Management of AMI Patients | 02-14-12 |
| Leavitt Partners and Park City Group Unite to Build a Global Food and Drug Safety Registry | 02-14-12 |
| Diffusion Pharmaceuticals?????????????TSC???????? | 02-14-12 |
| U.S. FDA Grants Priority Review for Truvada® for Reducing the Risk of Acquiring HIV Infection | 02-14-12 |
| Navidea President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO | 02-13-12 |
| Samenvatting: Diffusion Pharmaceuticals start klinisch onderzoek van TSC; een nieuw medicijn tegen hersenkanker | 02-13-12 |
| FDA Approves ZIOPTAN? (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication | 02-13-12 |
| Diffusion Pharmaceuticals Begins Clinical Trial of TSC, a New Drug for Treatment of Primary Brain Cancer | 02-13-12 |
| Riassunto: Diffusion Pharmaceuticals inizia la sperimentazione clinica per il TSC, un nuovo farmaco per il trattamento del cancro al cervello primario | 02-13-12 |
| Diffusion Pharmaceuticals Comienza Ensayo Clínico con TSC, un Nuevo Fármaco para el Tratamiento de Cáncer Cerebral Primario | 02-13-12 |
| Diffusion Pharmaceuticals beginnt Studie über TSC, ein neues Arzneimittel zur Behandlung von primären Gehirntumoren | 02-13-12 |
